|
|
| Press Releases |
|
 |
LLTP
to Develop Opioid Drug Treatment with National Institute on
Drug Abuse |
April 24, 2013 |
|
|
LLTP
Provides Guidance on Company Operations |
April 4, 2013 |
|
|
LLTP Presents Clinical Trial Results to APA |
March 27, 2013 |
|
|
LLTP Appoints Kevin Pollack New CFO |
November 29, 2012 |
|
|
LLTP Appoints
Dr. David Kessler as Strategic Advisor |
September 24, 2012 |
|
|
LLTP Announces Positive Preliminary Phase II Clinical Trial
Results of Binge Eating Disorder Treatment |
May3,
2012 |
|
|
LLTP
Appoints Pollack to Board |
April 17, 2012 |
|
|
LLTP Responds to Questions
About Trading Activity |
Feb 1, 2012 |
|
|
LLTP Applies Patented Technology to New
Treatment for PMS Overeating |
Jan 6, 2012 |
|
|
LLTP Discusses New Opiate Overdose
Treatment with King's College, London |
Jan 3, 2012 |
|
|
LLTP to Conduct Phase II Testing of New Bulimia Nervosa Treatment at King’s College, London |
Oct 05, 2011 |
|
|
|
|
